DENVER, Dec. 17 /PRNewswire-FirstCall/ -- Global Med Technologies®, Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international healthcare information technology company, today announced that its Inlog, SA subsidiary has licensed its EdgeLab™ Laboratory Information Management Software (Marketed as "Labo Serveur" in France) to the centuries-old Centre Hospitalier de Verdun in Verdun, France. Terms of the agreement were not disclosed.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
EdgeLab is a leading laboratory information management system in Europe used by more than 150 licensed laboratories. EdgeLab can be interfaced to more than 1,000 analyzers and interchanges data with all major hospital healthcare software applications. Its comprehensive range of laboratory functionality can be easily configured to meet the business needs of large, diverse, multi-site hospital laboratories, as well as small, single-site hospitals. The Verdun Hospital Laboratory will use EdgeLab to process over 350 patient files per day. The system will be interfaced to six analyzers and one instrument middleware product.
Will Willman, Global Med's Sr. Vice President of Sales and Marketing EU/ME/Asia, stated, "We are very pleased that the historic Centre Hospitalier de Verdun has selected Inlog's EdgeLab solution to upgrade their laboratory software. Verdun's decision was a result of the excellent references that our software received from the Inlog customers that Verdun contacted, the full range of features the software offers, the integrated SapaNet (El Dorado Control) quality management software, and the ability to interface to our EdgeTrack transfusion management software (not for sale in the U.S.) on the same database."
About Centre Hospitalier de Verdun
The Verdun Hospitals have a rare and fascinating history. Founded in the 7th century, the first written evidence of a care facility near the current location was in 1093. The hospital has evolved through the centuries: the thirteenth century saw a name change to Sainte-Catherine; in 1570 a general hospital was formed; during the French Revolution the organization Hospices Civils de Verdun (Sainte-Catherine and Saint-Nicolas) was created; Sainte-Catherine was partially destroyed during WWI, and then repaired; St. Nicolas was used as a military hospital during WWII. Between World War II and 2007, Verdun hospitals expanded to four separate facilities including Desandrouins and Saint Joseph. At almost 1,000 beds in three different sites, Verdun handles about 25,000 emergencies per year. Nearly 1,800 people work at the hospital including more than 170 physicians.
About Global Med Technologies®, Inc.
Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med's products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites.
Global Med's domestic companies are Wyndgate Technologies®, a leader in software products and services for donor centers and hospital transfusion services; eDonor®, which offers web-based donor relationship management systems; Hemo-Net®, a healthcare application service provider; and PeopleMed®, Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.
For more information about Global Med's products and services, please call 800-996-3428 or visit www.globalmedtech.com.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
SOURCE Global Med Technologies, Inc.
Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
EdgeLab is a leading laboratory information management system in Europe used by more than 150 licensed laboratories. EdgeLab can be interfaced to more than 1,000 analyzers and interchanges data with all major hospital healthcare software applications. Its comprehensive range of laboratory functionality can be easily configured to meet the business needs of large, diverse, multi-site hospital laboratories, as well as small, single-site hospitals. The Verdun Hospital Laboratory will use EdgeLab to process over 350 patient files per day. The system will be interfaced to six analyzers and one instrument middleware product.
Advertisement
Will Willman, Global Med's Sr. Vice President of Sales and Marketing EU/ME/Asia, stated, "We are very pleased that the historic Centre Hospitalier de Verdun has selected Inlog's EdgeLab solution to upgrade their laboratory software. Verdun's decision was a result of the excellent references that our software received from the Inlog customers that Verdun contacted, the full range of features the software offers, the integrated SapaNet (El Dorado Control) quality management software, and the ability to interface to our EdgeTrack transfusion management software (not for sale in the U.S.) on the same database."
About Centre Hospitalier de Verdun
The Verdun Hospitals have a rare and fascinating history. Founded in the 7th century, the first written evidence of a care facility near the current location was in 1093. The hospital has evolved through the centuries: the thirteenth century saw a name change to Sainte-Catherine; in 1570 a general hospital was formed; during the French Revolution the organization Hospices Civils de Verdun (Sainte-Catherine and Saint-Nicolas) was created; Sainte-Catherine was partially destroyed during WWI, and then repaired; St. Nicolas was used as a military hospital during WWII. Between World War II and 2007, Verdun hospitals expanded to four separate facilities including Desandrouins and Saint Joseph. At almost 1,000 beds in three different sites, Verdun handles about 25,000 emergencies per year. Nearly 1,800 people work at the hospital including more than 170 physicians.
About Global Med Technologies®, Inc.
Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med's products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites.
Global Med's domestic companies are Wyndgate Technologies®, a leader in software products and services for donor centers and hospital transfusion services; eDonor®, which offers web-based donor relationship management systems; Hemo-Net®, a healthcare application service provider; and PeopleMed®, Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.
For more information about Global Med's products and services, please call 800-996-3428 or visit www.globalmedtech.com.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
SOURCE Global Med Technologies, Inc.
